No Result
View All Result
  • MISSION STATEMENT
  • CONTACT
  • BE PART OF QUALITY JOURNALISM
  • ARCHIVE
Thursday, September 21, 2023
E-Paper
Kashmir Observer
20 °c
Srinagar
  • NEWSLIVE
    • TOP STORIES
    • LOCAL
    • CITY
    • REGIONAL
    • WORLD
  • IN DEPTH
    • FEATURE
    • HEADS & TAILS
    • OPINION
      • OPINION
      • EDITORIAL
      • KO ANALYSIS
      • LETTERS TO EDITOR
    • SPECIAL REPORT
    • INTERVIEW
    • REVIEW
      • BOOKS
    • LONGFORM
  • BUSINESS
    • BUSINESS NEWS
    • MARKET
    • ENERGY
    • HORTICULTURE
    • HANDICRAFTS
    • CARS & BIKES
    • STARTUP KASHMIR
  • SPORT
    • FOOTBAL
    • CRICKET
    • ADVENTURE SPORTS
    • GOLF
    • ATHLETICS
    • SKIING
    • OTHER SPORTS
  • MEDIA
  • PEOPLE
  • CULTURE
    • KHYEN CHYEN
    • ARTS
    • CRAFTS
    • FESTIVALS
    • THEATER
    • LANGAUGE
  • TRAVEL
    • HOUSEBOATS
    • HOTELS
    • ANGLING
    • CAMPING
    • DESTINATION FOCUS
  • SOCIETY
    • EDUCATION
    • HEADS & TAILS
    • GENDER
    • YOUTH
    • CHILD WELFARE
  • LITERATURE
    • SHORT STORY
    • BOOKS
    • NARRATIVE
  • CINEMA
    • CINEMA & TV
  • ePAPERS
    • BAZAAR OBSERVER
    • YOUNG KASHMIR
    • MIZRAB
  • NEWSLIVE
    • TOP STORIES
    • LOCAL
    • CITY
    • REGIONAL
    • WORLD
  • IN DEPTH
    • FEATURE
    • HEADS & TAILS
    • OPINION
      • OPINION
      • EDITORIAL
      • KO ANALYSIS
      • LETTERS TO EDITOR
    • SPECIAL REPORT
    • INTERVIEW
    • REVIEW
      • BOOKS
    • LONGFORM
  • BUSINESS
    • BUSINESS NEWS
    • MARKET
    • ENERGY
    • HORTICULTURE
    • HANDICRAFTS
    • CARS & BIKES
    • STARTUP KASHMIR
  • SPORT
    • FOOTBAL
    • CRICKET
    • ADVENTURE SPORTS
    • GOLF
    • ATHLETICS
    • SKIING
    • OTHER SPORTS
  • MEDIA
  • PEOPLE
  • CULTURE
    • KHYEN CHYEN
    • ARTS
    • CRAFTS
    • FESTIVALS
    • THEATER
    • LANGAUGE
  • TRAVEL
    • HOUSEBOATS
    • HOTELS
    • ANGLING
    • CAMPING
    • DESTINATION FOCUS
  • SOCIETY
    • EDUCATION
    • HEADS & TAILS
    • GENDER
    • YOUTH
    • CHILD WELFARE
  • LITERATURE
    • SHORT STORY
    • BOOKS
    • NARRATIVE
  • CINEMA
    • CINEMA & TV
  • ePAPERS
    • BAZAAR OBSERVER
    • YOUNG KASHMIR
    • MIZRAB
No Result
View All Result
Kashmir Observer
No Result
View All Result
Home NEWS TOP STORIES

New Cancer Drug For Multiple Sclerosis Best Treatment: Report

by Observer News Service
November 6, 2012
A A
0
SHARES
3
VIEWS

LONDON – Researchers have identified that a type of cancer drug can help people with early multiple sclerosis relapsed on previous drugs as well as patients who failed in treatment.

A new study conducted at the University of Cambridge indicated that a drug which reboots a person’s immune system proved to be an effective treatment for multiple sclerosis (MS) patients. 

According to the study published in the journal The Lancet, the drug known as ‘alemtuzumab’, which previously used to treat a type of leukemia, through wiping out and resetting the immune system, has shown better results than other current options for MS patients. 

ADVERTISEMENT

The drug significantly lowers the number of attacks (or relapses) experienced by people with MS compared to those patients who are treated with current drug, interferon beta-1a.

Moreover, the study revealed that patients taking alemtuzumab had less disability than when they started the trial whereas those who were on interferon therapy had experienced worsening disability. 

Read Also

Constitution Cannot Be Amended So Easily: Omar Abdullah

Srinagar’s Bilquis Mir Appointed Senior Canoeing, Kayaking Judge At Asian Games

The effective result was seen both in patients who had not previously received any treatment and those who have continued to show disease activity whilst taking an existing treatment for MS.

“Although other MS drugs have emerged over the last year, which is certainly good news for patients, none has shown superior effects on disability when compared to interferon except alemtuzumab,” said Dr Alasdair Coles, from the University of Cambridge. 

“It is certainly the most effective MS drug, based on these clinical trials, but this is definitely not a cure,” he noted. 

MS is an autoimmune disease in which the body’s immune system mistakenly attacks nerve fibres and their protective insulation. The resulting damage prevents the nerves from ‘firing’ properly and ultimately leads to the loss of the nerve fibre and consequently physical and cognitive disabilities.

Follow this link to join our WhatsApp group: Join Now

Be Part of Quality Journalism

Quality journalism takes a lot of time, money and hard work to produce and despite all the hardships we still do it. Our reporters and editors are working overtime in Kashmir and beyond to cover what you care about, break big stories, and expose injustices that can change lives. Today more people are reading Kashmir Observer than ever, but only a handful are paying while advertising revenues are falling fast.

ACT NOW
MONTHLYRs 100
YEARLYRs 1000
LIFETIMERs 10000

CLICK FOR DETAILS

ShareTweetSendShareShareSend
Previous Post

Over 500 pigeons drop dead in Bihar village

Next Post

World destined for dangerous climate change this century

Observer News Service

Observer News Service

Related Posts

Constitution Cannot Be Amended So Easily: Omar Abdullah
LOCAL

Constitution Cannot Be Amended So Easily: Omar Abdullah

Srinagar's Bilquis Mir Appointed Senior Canoeing, Kayaking Judge At Asian Games
OTHER SPORTS

Srinagar’s Bilquis Mir Appointed Senior Canoeing, Kayaking Judge At Asian Games

J&K ANTF Arrests Border Resident With 3.5 Kg Heroin
LOCAL

J&K ANTF Arrests Border Resident With 3.5 Kg Heroin

Husband Allegedly Hammers Wife To Death In J&K's Poonch, Arrested
LOCAL

Husband Allegedly Hammers Wife To Death In J&K’s Poonch, Arrested

Police Officer Sheikh Adil Arrested In Srinagar
LOCAL

Police Officer Sheikh Adil Arrested In Srinagar

Ready To Discuss Issue With Full Courage: Rajnath On Issue Of Border Standoff With China
REGIONAL

Ready To Discuss Issue With Full Courage: Rajnath On Issue Of Border Standoff With China

Next Post

World destined for dangerous climate change this century

Sensex gains for the fourth day; defensives lead

Please login to join discussion

Pages

  • ABOUT US
  • ADVERTISE IN KO
  • ARCHIVE
  • BE PART OF QUALITY JOURNALISM
  • CONTACT
  • CONTRIBUTORS
  • INTERNSHIPS AT OBSERVER
  • JOBS@KO
  • KO – Homepage
  • MISSION STATEMENT
  • POLICIES
    • COMMENTING GUIDELINES
    • COOKIE POLICY
    • DISCLAIMER
    • PRIVACY POLICY
    • TERMS
  • Refund Policy
  • Team

SEARCH IN ARCHIVE

No Result
View All Result

FOLLOW US

About Us

The media in Kashmir, comprising a robust English and vernacular press has a particularly unenviable job to do. The problems faced by it are both universal to the conflict situations and unique to the region. Read More

Advertising

For Advertising on various Kashmir Observer platforms
contact

[email protected]
+91-194-2502327; +91-1947969705

© 1997 -2023 | KASHMIR OBSERVER LLP

No Result
View All Result
  • NEWS
    • TOP STORIES
    • LOCAL
    • CITY
    • REGIONAL
    • WORLD
  • IN DEPTH
    • FEATURE
    • HEADS & TAILS
    • OPINION
      • OPINION
      • EDITORIAL
      • KO ANALYSIS
      • LETTERS TO EDITOR
    • SPECIAL REPORT
    • INTERVIEW
    • REVIEW
      • BOOKS
    • LONGFORM
  • BUSINESS
    • BUSINESS NEWS
    • MARKET
    • ENERGY
    • HORTICULTURE
    • HANDICRAFTS
    • CARS & BIKES
    • STARTUP KASHMIR
  • SPORT
    • FOOTBAL
    • CRICKET
    • ADVENTURE SPORTS
    • GOLF
    • ATHLETICS
    • SKIING
    • OTHER SPORTS
  • MEDIA
  • PEOPLE
  • CULTURE
    • KHYEN CHYEN
    • ARTS
    • CRAFTS
    • FESTIVALS
    • THEATER
    • LANGAUGE
  • TRAVEL
    • HOUSEBOATS
    • HOTELS
    • ANGLING
    • CAMPING
    • DESTINATION FOCUS
  • SOCIETY
    • EDUCATION
    • HEADS & TAILS
    • GENDER
    • YOUTH
    • CHILD WELFARE
  • LITERATURE
    • SHORT STORY
    • BOOKS
    • NARRATIVE
  • CINEMA
    • CINEMA & TV
  • ePAPERS
    • BAZAAR OBSERVER
    • YOUNG KASHMIR
    • MIZRAB

© 1997 -2023 | KASHMIR OBSERVER LLP